Genetic Determinants of Congenital Heart Disease Outcomes (GECHO)
The GECHO Trial: Genetic Determinants of Congenital Heart Disease Outcomes
Sponsor: Emory University
Listed as NCT01656941, this observational or N/A phase trial focuses on Congenital Heart Disease and Hypoplastic Left Heart Syndrome and remains completed. Sponsored by Emory University, it has been updated 14 times since 2011, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Sep 2021 — Dec 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting
▶ Show 9 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Active Not Recruiting
-
Jul 2019 — Aug 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jul 2018 — Jul 2019 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Mar 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Emory University
- Medical College of Wisconsin
- Medical University of South Carolina
- Royal Children's Hospital
- University of Michigan
For direct contact, visit the study record on ClinicalTrials.gov .